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Ovarian cancer in endometriosis (Yamaguchi et al.) 3 has disclosed that a high-iron microenvironment exists in ovarian endometriotic cysts, and that this may be related to clear cell carcinogenesis that is characterized by the expression of specifi c genes. Against this background, this review covers recent progress in the important area of ovarian cancer and endometriosis. Endometriosis is a unique disease entity in which ectopic endometrial-like tissues exist in the ovary, pelvic peritoneum, and various other sites in young women; this entity produces severe symptoms and effects such as dysmenorrhea, dyspareunia, pelvic pain, and infertility. Recently, endometriosis has also received much attention as an important origin of cancer. 1 Although among various histological types of ovarian carcinoma, clear cell and endometrioid adenocarcinomas are known to arise frequently in ovarian endometriotic cysts, little was known about the incidence, molecular mechanisms, natural clinical course, possibility of early detection, or treatment strategy for these two types of ovarian carcinoma. Recently, however, there has been prominent progress in this fi eld. Kobayashi's group 2 has reported that the possible incidence of malignant transformation of ovarian endometriotic cysts is 0.7%, based on the prospective follow-up of cohorts in the ovarian cancer screening program of Shizuoka Prefecture, Japan. In regard to the molecular basis of malignant change, Mandai's group
